Pharmaceutical Executive
January 05, 2016
Columns
35
12
How a broader “value” understanding can benefit brand teams.
December 21, 2015
Columns
35
12
Cleveland Clinic’s Top Medical Innovations for 2016.
December 20, 2015
Columns
35
12
The eight trends brought on by “once-and-done” interventions that may transform thinking around healthcare marketing.
December 10, 2015
Features
35
12
Pharm Exec talks with David Dosa, a leading physician in geriatric medicine, whose famous work with a cat named oscar in end-of-life diagnostics became the stuff of therapeutic legend.
December 08, 2015
Features
35
12
A Pharm Exec conversation with AmerisourceBergen CEO Steve Collis
December 08, 2015
Columns
35
12
Drug pricing backlash threatens regulatory reform, R&D advances
December 08, 2015
Features
35
12
Senior Editor Casey McDonald visits with industry and regulatory officials in Bogotá to discuss colombia’s strategy for growing its life sciences enterprise, and whether it can be a stable force amid the region’s historically challenging macroeconomic and political fluctuations.
December 07, 2015
From the Editor
35
12
A new discipline-population health-contests disease treatment as an end in itself. It asks: besides advancing the science of medicine, what do biopharmaceuticals actually do to improve health overall?
December 01, 2015
Columns
35
12
The Council of Europe is the latest group to jump into the drug-pricing debate blazing its way through continent.